Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Proofpoint Expects Pricing IPO In $10-$12/Shr Range - Quick Facts

RELATED NEWS
Trade PFPT now with 

Proofpoint, Inc. said it estimates pricing the initial public offering of its common stock in a range between $10.00 and $12.00 per share.

The company is selling 5 million shares of common stock and the selling stockholders identified in this prospectus are selling 1.199 million shares of common stock. Proofpoint said it will not receive any of the proceeds from the sale of shares of common stock by the selling stockholders.

Prior to this offering, there has been no public market for the company's common stock. Proofpoint has applied to list its common stock on the NASDAQ Global Market under the symbol "PFPT."

The underwriters have the option to purchase from the company a maximum of 750 thousand additional shares and from the selling stockholders a maximum of 179,914 additional shares to cover over-allotments of shares.

Click here to receive FREE breaking news email alerts for Proofpoint, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved sharply lower over the course of the trading day on Wednesday, adding to the modest weakness seen in the two previous sessions. With the losses on the day, the major averages fell to their lowest closing levels in over a month. Democrats have climbed into the lead on a generic ballot, according to the results of a new CNN/ORC International poll, although the results may not be as positive for the party as they first appear. With spending on private and public construction both showing notable decreases, the Commerce Department released a report on Wednesday showing an unexpected drop in U.S. construction spending in the month of August.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.